ANXA5 and acute myeloid leukemia: Then, all compounds were tested against U937 acute myeloid leukemia (AML) and HL60 acute promyelocytic leukemia (APL) cell lines to detect their antiproliferative effect, and for the most potent compounds (2a–c and 4a–c) the cell death mechanism (apoptosis through the sub-G1 peak, caspase activation, and annexin V induction) in U937 cells was evaluated.